These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 29786994)
1. The role of microRNAs in endometrial cancer and influence on future therapy: focusing on miRNA-21. Rak B; Marczewska JM; Wlodarski P Eur J Gynaecol Oncol; 2016; 37(5):599-603. PubMed ID: 29786994 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA: The Potential Regulator of Endometrial Carcinogenesis. Kontomanolis EN; Koukourakis MI Microrna; 2015; 4(1):18-25. PubMed ID: 26088599 [TBL] [Abstract][Full Text] [Related]
3. The expression of MMP-14 and microRNA-410 in FFPE tissues of human endometrial adenocarcinoma. Rak B; Garbicz F; Paskal W; Pełka K; Marczewska JM; Wołosz D; Włodarski P Histol Histopathol; 2016 Aug; 31(8):911-20. PubMed ID: 26842619 [TBL] [Abstract][Full Text] [Related]
4. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies. Logan M; Hawkins SM Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164 [TBL] [Abstract][Full Text] [Related]
5. The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application. Stope MB; Koensgen D; Weimer J; Paditz M; Burchardt M; Bauerschlag D; Mustea A Arch Gynecol Obstet; 2016 Nov; 294(5):889-895. PubMed ID: 27637583 [TBL] [Abstract][Full Text] [Related]
6. The role of miRNAs in endometrial cancer. Vasilatou D; Sioulas VD; Pappa V; Papageorgiou SG; Vlahos NF Epigenomics; 2015; 7(6):951-9. PubMed ID: 26443384 [TBL] [Abstract][Full Text] [Related]
7. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer. Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888 [TBL] [Abstract][Full Text] [Related]
8. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication. He S; Zeng S; Zhou ZW; He ZX; Zhou SF Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820 [TBL] [Abstract][Full Text] [Related]
9. [Differential expression of microRNAs as the novel potential diagnostic tool for the endometrial carcinoma]. Záveský L; Turyna R; Kohoutová M Ceska Gynekol; 2013 Nov; 78(5):432-42. PubMed ID: 24313429 [TBL] [Abstract][Full Text] [Related]
10. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist. Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia- and acidosis-driven aberrations of secreted microRNAs in endometrial cancer in vitro. Eismann J; Hirschfeld M; Erbes T; Rücker G; Jäger M; Ritter A; Weiss D; Gitsch G; Mayer S Oncol Rep; 2017 Aug; 38(2):993-1004. PubMed ID: 28627686 [TBL] [Abstract][Full Text] [Related]
13. Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review. Ravegnini G; Gorini F; De Crescenzo E; De Leo A; De Biase D; Di Stanislao M; Hrelia P; Angelini S; De Iaco P; Perrone AM Int J Cancer; 2022 Apr; 150(7):1077-1090. PubMed ID: 34706070 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Boren T; Xiong Y; Hakam A; Wenham R; Apte S; Wei Z; Kamath S; Chen DT; Dressman H; Lancaster JM Gynecol Oncol; 2008 Aug; 110(2):206-15. PubMed ID: 18499237 [TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis. Zheng X; Liu M; Song Y; Feng C Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α. Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells. Zhang H; Wang X; Chen Z; Wang W Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):96-101. PubMed ID: 26638889 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and their role in gynecological tumors. Torres A; Torres K; Maciejewski R; Harvey WH Med Res Rev; 2011 Nov; 31(6):895-923. PubMed ID: 20358579 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-21 in gynecological cancers: From molecular pathogenesis to clinical significance. Jiang NJ; Yin YN; Lin J; Li WY; Long DR; Mei L Pathol Res Pract; 2023 Aug; 248():154630. PubMed ID: 37393665 [TBL] [Abstract][Full Text] [Related]
20. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression. Chen S; Zong ZH; Wu DD; Sun KX; Liu BL; Zhao Y Mol Carcinog; 2017 Apr; 56(4):1361-1371. PubMed ID: 27991682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]